Tebentafusp-Tebn Clinical Trials

2 actively recruiting trials across 1 location

Also known as: IMCgp100, KIMMTRAK®, gp100 peptide-HLA-directed CD3 T cell engager, kimmtrak

Filter by location:

Philadelphia, Pennsylvania2 trials

Neoadjuvant Tebentafusp for Uveal Melanoma

Sidney Kimmel Cancer Center at Thomas Jefferson University

Phase 2

Tebentafusp-tebn With LDT in Metastatic UM

Thomas Jefferson University

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.